<?xml version="1.0" encoding="UTF-8"?>
<p>Other immunomodulators are being considered, including adalimumab. As mentioned above, TNF-Î± is an inflammatory mediator that is upregulated in SARS-CoV-2. Adalimumab is a TNF inhibitor and may show effective inhibition of SARS-CoV-2 pneumonia [
 <xref rid="B71" ref-type="bibr">71</xref>].
</p>
